Tyra Biosciences, Inc. TYRA Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s change in AP?
- Tyra Biosciences, Inc. (TYRA) reported change in AP of $1.2M in Q1 2026.
- How has Tyra Biosciences, Inc.'s change in AP changed year-over-year?
- Tyra Biosciences, Inc.'s change in AP increased by 427.4% year-over-year, from -$365K to $1.2M.
- What is the long-term trend for Tyra Biosciences, Inc.'s change in AP?
- Over 3 years (2021 to 2025), Tyra Biosciences, Inc.'s change in AP has grown at a 31.2% compound annual growth rate (CAGR), from $1.49M to $3.37M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.